Cargando…

Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients

Adaptive natural killer (NK) cell responses to human cytomegalovirus infection are characterized by the expansion of NKG2C(+) NK cells expressing self-specific inhibitory killer-cell immunoglobulin-like receptors (KIRs). Here, we set out to study the HLA class I dependency of such NKG2C(+) NK cell e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Béziat, Vivien, Sleiman, Marwan, Goodridge, Jodie P., Kaarbø, Mari, Liu, Lisa L., Rollag, Halvor, Ljunggren, Hans-Gustaf, Zimmer, Jacques, Malmberg, Karl-Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594010/ https://www.ncbi.nlm.nih.gov/pubmed/26500647 http://dx.doi.org/10.3389/fimmu.2015.00507

Ejemplares similares

Immune selection during tumor checkpoint inhibition therapy paves way for NK-cell “missing self” recognition
por: Malmberg, Karl-Johan, et al.
Publicado: (2017)

Tracing dynamic expansion of human NK-cell subsets by high-resolution analysis of KIR repertoires and cellular differentiation
por: Béziat, Vivien, et al.
Publicado: (2014)

Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans
por: Liu, Lisa L., et al.
Publicado: (2016)

NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs
por: Béziat, Vivien, et al.
Publicado: (2010)

The NK cell checkpoint NKG2A maintains expansion capacity of human NK cells
por: Kaulfuss, Meike, et al.
Publicado: (2023)

Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus
por: Björkström, Niklas K., et al.
Publicado: (2011)

SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells
por: Hammer, Quirin, et al.
Publicado: (2022)

Expansion of NK Cells and Reduction of NKG2D Expression in Chronic Lymphocytic Leukemia. Correlation with Progressive Disease
por: Huergo-Zapico, Leticia, et al.
Publicado: (2014)

Paths taken towards NK cell–mediated immunotherapy of human cancer—a personal reflection
por: Ljunggren, Hans‐Gustaf
Publicado: (2020)

Selective Expansion of NKG2C+ Adaptive NK Cells Using K562 Cells Expressing HLA-E
por: Phan, Minh-Trang Thi, et al.
Publicado: (2022)

NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme
por: Murad, Shafiq, et al.
Publicado: (2022)

Unexpected lack of specificity of a rabbit polyclonal TAP-L (ABCB9) antibody
por: van Endert, Peter, et al.
Publicado: (2015)

Potential of the NKG2D/NKG2DL Axis in NK Cell-Mediated Clearance of the HIV-1 Reservoir
por: Desimio, Maria G., et al.
Publicado: (2019)

Expansions of adaptive-like NK cells with a tissue-resident phenotype in human lung and blood
por: Brownlie, Demi, et al.
Publicado: (2021)

Inhibitory NKG2A(+) and absent activating NKG2C(+) NK cell responses are associated with the development of EBV(+) lymphomas
por: Vietzen, Hannes, et al.
Publicado: (2023)

Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma
por: Rosenberg, Miriam I., et al.
Publicado: (2023)

Adaptive single-KIR(+)NKG2C(+) NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia
por: Haroun-Izquierdo, Alvaro, et al.
Publicado: (2022)

Chronic NKG2D Engagement In Vivo Differentially Impacts NK Cell Responsiveness by Activating NK Receptors
por: Koch, Christine, et al.
Publicado: (2017)

Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns
por: Haik, Josef, et al.
Publicado: (2015)

Newtonian cell interactions shape natural killer cell education
por: Goodridge, Jodie P., et al.
Publicado: (2015)

NKG2A is a NK cell exhaustion checkpoint for HCV persistence
por: Zhang, Chao, et al.
Publicado: (2019)

High Metabolic Function and Resilience of NKG2A-Educated NK Cells
por: Highton, Andrew J., et al.
Publicado: (2020)

Responsiveness to Influenza Vaccination Correlates with NKG2C-Expression on NK Cells
por: Riese, Peggy, et al.
Publicado: (2020)

Dissection of the NKG2C NK cell response against Puumala Orthohantavirus
por: Vietzen, Hannes, et al.
Publicado: (2021)

CD56(dim)CD57(+)NKG2C(+) NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT
por: Cichocki, Frank, et al.
Publicado: (2015)

A Role for NKG2D in NK Cell–Mediated Resistance to Poxvirus Disease
por: Fang, Min, et al.
Publicado: (2008)

Activating KIRs and NKG2C in Viral Infections: Toward NK Cell Memory?
por: Della Chiesa, Mariella, et al.
Publicado: (2015)

NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML
por: Schlegel, Patrick, et al.
Publicado: (2015)

Endothelial cells express NKG2D ligands and desensitize antitumor NK responses
por: Thompson, Thornton W, et al.
Publicado: (2017)

Intratumoral co‐injection of NK cells and NKG2A‐neutralizing monoclonal antibodies
por: Melero, Ignacio, et al.
Publicado: (2023)

Alessandro Moretta and Transporter Associated With Antigen Processing (TAP) Deficiency: On Giant's Shoulders
por: Zimmer, Jacques
Publicado: (2019)

NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell development
por: Jelenčić, Vedrana, et al.
Publicado: (2018)

Regulation of NKG2D-Dependent NK Cell Functions: The Yin and the Yang of Receptor Endocytosis
por: Molfetta, Rosa, et al.
Publicado: (2017)

NKG2D modulates aggravation of liver inflammation by activating NK cells in HBV infection
por: Wang, Yadong, et al.
Publicado: (2017)

Circulating CD56+ NKG2D+ NK cells and postoperative fertility in ovarian endometrioma
por: Liu, Zhi-Qin, et al.
Publicado: (2020)

Tumor-Derived Soluble MICA Obstructs the NKG2D Pathway to Restrain NK Cytotoxicity
por: Luo, Qizhi, et al.
Publicado: (2020)

Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells
por: Bryceson, Yenan T., et al.
Publicado: (2005)

Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia
por: Märklin, Melanie, et al.
Publicado: (2019)

Large-Scale In Vitro Expansion of Polyclonal Human Switched-Memory B Lymphocytes
por: Néron, Sonia, et al.
Publicado: (2012)

NK cell receptor NKG2D enforces proinflammatory features and pathogenicity of Th1 and Th17 cells
por: Babic, Marina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r2ljaarc9v885ka5ap6e5vlj7f